Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2016
Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium TrialJoseph A Sparano, Jeannette Y Lee, Joel Palefsky, et al.Clinical Colorectal Cancer|April 17, 2017
Comparative Effectiveness Research: The Impact of Biologic Agents in Ethnic Minorities With Metastatic Colorectal CancerSanjay Goel, Abdissa Negassa, Ashish Khot, et al.Eclinicalmedicine|December 25, 2024
International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome setRobert Samuel, Stephen R Knight, Richard Adams, et al.International Journal of Radiation Oncology, Biology, Physics|May 4, 2018
Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal CancerHoward Safran, Kara-Lynne Leonard, Kimberly Perez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline UpdateManish A Shah, Erin B Kennedy, Dana Deighton, et al.Oncotarget|October 1, 2019
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatinDevika Rao, Atrayee Basu Mallick, Titto Augustine, et al.Plos One|September 18, 2014
Humanized TLR7/8 expression drives proliferative multisystemic histiocytosis in C57BL/6 miceJessica M Snyder, Piper M Treuting, Lee Nagy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2024
Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO GuidelineVan K Morris, Erin B Kennedy, Manik A Amin, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2021
Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 StudyThomas A Rasmussen, Lakshmi Rajdev, Ajantha Rhodes, et al.Cancer|November 14, 2023
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 StudyLakshmi Rajdev, Chia-Ching Jackie Wang, Himanshu Joshi, et al.Pageof 5